-
Khachanov shocks ailing Auger-Aliassime, Swiatek and Osaka advance at US Open
-
Wilson back to lead Australia as Kiss rotates team for Argentina
-
Lone juror blocking verdict in US mother's child murder trial: defense
-
Yen surges on new intervention talk, US stocks rally
-
'Kinda chic' - Williams sisters set to launch US Open doubles bid
-
Japan's Ueda fires Lille top of Ligue 1 on debut
-
Volkswagen says cutting 100,000 jobs by end of decade
-
Arsenal chief executive reveals 'dynasty' ambition
-
Russia slaps curfew on charity director over army criticism
-
Spanish PM says no 'solid proof' Morocco planned migrant rush
-
Ailing Auger-Aliassime upset by Khachanov at US Open
-
Iran war is not a war, US VP Vance says
-
Richarlison omitted from Tottenham's Premier League squad
-
Khachanov stuns third-seeded Auger-Aliassime in US Open second round
-
How El Nino is choking the Panama Canal
-
Bordeaux facing sixth-tier football after French federation upholds relegation
-
Hamilton drives his Ferrari dream at Monza
-
Stoic Verstappen looking beyond 'painful' Monza weekend
-
Senegal has an IMF loan, now what?
-
OpenAI begins rollout of new powerful AI model GPT-6 Astra
-
Auger-Aliassime upset by Khachanov at US Open
-
FIFA blasts UEFA 'smear campaign,' fights World Cup plan disclosures
-
Hugging Face, the French start-up that became AI's warehouse
-
Zelensky hopes to host US envoys in Kyiv in 'coming days'
-
World Cup winner Llorente retires from Spain team at 31
-
Martinelli joins Al-Hilal from Arsenal for reported £60 million
-
Osaka squeezes into US Open third round
-
Tesla's semi-autonomous driving could be adapted to EU norms: France
-
Apple faces £2 bn lawsuit in UK over app privacy feature
-
37 people die from fumes during oil pipeline theft in Nigeria: NGO
-
Former champ Swiatek eases into US Open third round
-
Ahead of elections, Israel tests West's patience on West Bank violence
-
DR Congo latest to promise moving Israel embassy to Jerusalem
-
Antonelli will obey Mercedes orders to help 'tow' teammate Russell
-
War criminal Mladic's body returns to Serbia with military honours
-
UK fintech Revolut gains conditional US banking licence
-
Pierre Cardin museum brings designer's futurist style to Venice
-
Mara sisters channel childhood energy for twins performance at Venice
-
Slovenian rookie Omrzel triumphs as Mas extends Vuelta lead
-
UN's Sudan probe says foreign fighters fuelling conflict
-
British, French leaders talk migrants, EU relations
-
Violence erupts at S.Africa anti-migrant protest
-
Heading for Ferrari's home race, Leclerc still dreams of world title
-
Nothing left: Nepal flood survivors face loss and uncertainty
-
Cafe at centre of Israel culture clash agrees to shut on Sabbath
-
Tesla to launch self-driving 'Cybercab' in Texas
-
Spacecraft bound for Mercury begins 'tricky' arrival
-
Europe struggles to respond as Russia escalates shadow warfare
-
Initial expert report blames tanker for collision off Istanbul
-
Malta PM urges 'caution' after acquittal in journalist's murder
AVTRMed Selected as Member of NVIDIA Inception Program, Advancing its Enterprise AI Platform for Healthcare Delivery
Selection validates AVTRMed's technical architecture and accelerates its go-to-market strategy for scaling its intelligent automation platform
DAKOTA DUNES, SOUTH DAKOTA / ACCESS Newswire / February 9, 2026 / AVTRMed, Inc., a healthcare AI company building autonomous clinical workflow solutions, today announced its acceptance into the NVIDIA Inception program, a global initiative supporting startups developing transformative technologies in artificial intelligence and accelerated computing.
The NVIDIA Inception program provides AVTRMed with access to NVIDIA's advanced AI frameworks, infrastructure, technical expertise and capabilities to scale its eye care platform and later expand to additional healthcare verticals. Selection into the program validates AVTRMed's technical architecture and solidifies its position in the rapidly growing AI-enabled healthcare sector.
"Joining NVIDIA Inception is a strategic milestone that validates our mission and strengthens our foundation for sustained growth," says Dr. Steven Ferguson, CEO of AVTRMed. "This collaboration empowers AVTRMed to deliver high-impact clinical and operational AI solutions at scale, alongside leading innovators in healthcare AI."
AVTRMed is developing a next-generation platform designed to address structural inefficiencies in healthcare delivery through intelligent, autonomous digital workflows. The company's AI Clinic Assistant is currently deployed in live clinical eye care environments, demonstrating meaningful reductions in administrative workload and improvements in patient appointment adherence. As healthcare organizations increasingly seek AI solutions that deliver immediate ROI and integrate seamlessly with existing infrastructure, AVTRMed's focus on performance and enterprise deployment positions the company to capture value in a market undergoing fundamental transformation.
NVIDIA Inception fuels AVTRMed's ability to scale and future-proof its platform without compromising the rigorous security and compliance that healthcare demands.
For more information about AVTRMed and its AI platform, visit AVTRMed.com or connect with the company on LinkedIn.
About AVTRMed, Inc.
AVTRMed is a healthcare AI company building scalable platforms that augment clinical and operational workflows through advanced artificial intelligence. The company's mission is to enable more efficient, accessible and human-centered healthcare delivery. AVTRMed's AI Clinic Assistant platform serves eye care practices with autonomous solutions for patient engagement and administrative automation. Learn more at www.avtrmed.com.
About NVIDIA Inception
NVIDIA Inception is designed to nurture startups revolutionizing industries with technological advancements. The program provides critical go-to-market support, expertise, and technology to members across the globe, spanning diverse industries from healthcare and finance to automotive and manufacturing. For more information, visit nvidia.com/en-us/startups.
END
Media Contact:
Brian Regan, COO
Phone: (919) 229-9594
Email: [email protected]
SOURCE: AVTRMed
View the original press release on ACCESS Newswire
P.Stevenson--AMWN